BioNTech SE et al v. CureVac AG

  1. May 19, 2023

    CureVac Lobs Infringement Counterclaims At BioNTech, Pfizer

    CureVac on Friday accused BioNTech and Pfizer of infringing nine of its patents covering COVID-19 technology, lodging counterclaims in the pharmaceutical companies' case, which was recently transferred from Massachusetts to Virginia federal court.

  2. May 17, 2023

    CureVac Gets Pfizer COVID Vax Patent Fight Moved To Va.

    A Massachusetts federal judge has shipped to Virginia a lawsuit brought by Pfizer and BioNTech seeking to find that they haven't infringed CureVac patents related to technology used in COVID-19 vaccines.

  3. December 05, 2022

    Pfizer, BioNTech Seek To Nix Moderna Vax IP Suit, Countersue

    Several Moderna patents related to technology behind the mRNA platform in COVID-19 vaccines are invalid, rival vaccine-makers Pfizer Inc. and BioNTech told a Massachusetts federal judge on Monday in a bid to dismiss Moderna's infringement suit and in counterclaims of their own.

  4. July 25, 2022

    BioNTech, Pfizer Say They Didn't Infringe CureVac Patents

    BioNTech and Pfizer on Monday asked a Massachusetts federal court to find that they haven't infringed CureVac patents related to COVID-19 vaccine technology, claiming that the drugmakers are facing threats of a "groundless patent infringement suit" from CureVac.